Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial
Hiddo J.L. Heerspink(University Medical Center Groningen), Bi‐Cheng Liu(Nanfang Hospital), George L. Bakris(Pennsylvania State System of Higher Education), Svetla Stamova, Peter Doubel, Nicholas A. Gray(Sunshine Coast University Hospital), Brendon L. Neuen(The George Institute for Global Health), Irena Dimitrova, Marijn M. Speeckaert(Ghent University Hospital), Miguel Hominal, Vlado Perkovic(New South Wales Department of Health), Paola Aguerre(FIND), Pantelis Sarafidis(Ippokrateio General Hospital of Thessaloniki), David Z.I. Cherney(University Health Network), Christoph Wanner(Universitätsklinikum Würzburg), Eugenia Pedagogos, Rafaël Maldonado(FIND), Jenny Chen(Johns Hopkins University), Sara Dizayee(University of Cologne), Celine Foote(Tufts Medical Center), Natalia Cluigt, Katherine R. Tuttle(Providence Regional Medical Center Everett), Patrick Schloemer(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Yordanka Ivanova, Peter Kolkhof(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Laura Labriola(Yamaha (Japan)), Meike Brinker(Bayer (Germany)), Shuifu Tang(Queen Mary Hospital), Carolyn S.P. Lam(University of Glasgow), Paula Vesterinen(Ferring Pharmaceuticals (Finland)), David Packham(The Royal Melbourne Hospital), Kathleen Claes(KU Leuven), Cesar Javier Zaidman, Sunil V. Badve(UNSW Sydney), Elizabeth Gelersztein, Bart Maes(AZ Delta), Darren J. Lee, Carmel M. Hawley(The University of Queensland), Rajiv Agarwal(Richard L. Roudebush VA Medical Center), Fernando Halac, Tsvetelina Vutova, Stefan Ilchev, Xudong Xu(Fudan University), Xiangmei Chen(State Administration of Traditional Chinese Medicine of the People's Republic of China), Julio Bittar(FIND), Bernard Dubois, А М Васильева, M. Arriola(FIND), Mariano Chahin
Cited by 83
Related Papers
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
|Hypertension|2003|13.3k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k